Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function.

Veliz K, Shen F, Shestova O, Shestov M, Shestov A, Sleiman S, Hansen T, O'Connor RS, Gill S

Open source

DOI
10.1016/j.omton.2024.200819
Published
2024 Jun 20
Container
Molecular therapy. Oncology
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.omton.2024.200819,
  title = {Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function.},
  author = {Veliz K and Shen F and Shestova O and Shestov M and Shestov A and Sleiman S and Hansen T and O'Connor RS and Gill S},
  year = {2024},
  journal = {Molecular therapy. Oncology},
  doi = {10.1016/j.omton.2024.200819},
  url = {https://doi.org/10.1016/j.omton.2024.200819}
}

RIS

TY  - JOUR
TI  - Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function.
AU  - Veliz K
AU  - Shen F
AU  - Shestova O
AU  - Shestov M
AU  - Shestov A
AU  - Sleiman S
AU  - Hansen T
AU  - O'Connor RS
AU  - Gill S
PY  - 2024
JO  - Molecular therapy. Oncology
DO  - 10.1016/j.omton.2024.200819
UR  - https://doi.org/10.1016/j.omton.2024.200819
ER  - 

APA

K, V., F, S., O, S., M, S., A, S., S, S., T, H., RS, O., & S, G. (2024). Deletion of CD38 enhances CD19 chimeric antigen receptor T cell function.. Molecular therapy. Oncology. https://doi.org/10.1016/j.omton.2024.200819

Source records